In terms of revenue, the global cellular health screening market was valued at $xx million in 2022 and is expected to reach $xx million by 2032, growing at a CAGR of 9.32% during the forecast period 2023-2032.
The global computed tomography (CT) scanners market is expected to reach $12587.31 million by 2032, growing at a CAGR of 5.26% during the forecast period 2023-2032.
The Asia-Pacific computed tomography (CT) scanners market is set to progress with a CAGR of 5.90% over the forecasted years of 2023 to 2032, acquiring a revenue share of $2191.38 million by 2032.
The Europe computed tomography (CT) scanners market is anticipated to progress with a CAGR of 5.19% across the forecasting period of 2023 to 2032, acquiring a revenue share of $3516.89 million by 2032.
The North America computed tomography (CT) scanners market is predicted to register a CAGR of 5.09% over the projection period of 2023 to 2032, acquiring a revenue share of $4263.32 million by 2032.